David M Kaetzel
Overview
Explore the profile of David M Kaetzel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leonard M, Puts G, Pamidimukkala N, Adhikary G, Xu Y, Kwok E, et al.
Oncogene
. 2021 Oct;
40(45):6394.
PMID: 34635800
No abstract available.
2.
Leonard M, Puts G, Pamidimukkala N, Adhikary G, Xu Y, Kwok E, et al.
Oncogene
. 2021 Aug;
40(45):6329-6342.
PMID: 34433909
Hepatocyte growth factor-overexpressing mice that harbor a deletion of the Ink4a/p16 locus (HP mice) form melanomas with low metastatic potential in response to UV irradiation. Here we report that these...
3.
Pamidimukkala N, Puts G, Leonard M, Snyder D, Dabernat S, De Fabo E, et al.
Br J Cancer
. 2020 Oct;
124(1):161-165.
PMID: 33024267
NME1 is a metastasis-suppressor gene (MSG), capable of suppressing metastatic activity in cell lines of melanoma, breast carcinoma and other cancer origins without affecting their growth in culture or as...
4.
Snyder D, Wang Y, Kaetzel D
Sci Rep
. 2020 Feb;
10(1):1971.
PMID: 32029850
Despite recent advances in melanoma treatment, metastasis and resistance to therapy remain serious clinical challenges. NME1 is a metastasis suppressor, a class of proteins which inhibits metastatic spread of cancer...
5.
Wang Y, Leonard M, Snyder D, Fisher M, Eckert R, Kaetzel D
Mol Cancer Res
. 2019 May;
17(8):1665-1674.
PMID: 31123173
Melanoma is a lethal skin cancer prone to progression and metastasis, and resistant to therapy. Metastasis and therapy resistance of melanoma and other cancers are driven by tumor cell plasticity,...
6.
Leonard M, Novak M, Snyder D, Snow G, Pamidimukkala N, McCorkle J, et al.
Exp Cell Res
. 2018 Nov;
374(1):85-93.
PMID: 30458180
Expression of the metastasis suppressor NME1 in melanoma is associated with reduced cellular motility, invasion, and metastasis, but mechanisms underlying these activities are not completely understood. Herein we report a...
7.
Pamidimukkala N, Leonard M, Snyder D, McCorkle J, Kaetzel D
Anticancer Res
. 2018 Nov;
38(11):6059-6068.
PMID: 30396920
Background/aim: NME/NM23 nucleoside diphosphate kinase 1 (NME1) is a metastasis suppressor gene, exhibiting reduced expression in metastatic cancers and the ability to suppress metastatic activity of cancer cells. We previously...
8.
Leonard M, McCorkle J, Snyder D, Novak M, Zhang Q, Shetty A, et al.
Lab Invest
. 2017 Oct;
98(3):327-338.
PMID: 29058705
Although NME1 is well known for its ability to suppress metastasis of melanoma, the molecular mechanisms underlying this activity are not completely understood. Herein, we utilized a bioinformatics approach to...
9.
Puts G, Leonard M, Pamidimukkala N, Snyder D, Kaetzel D
Lab Invest
. 2017 Oct;
98(2):211-218.
PMID: 29058704
The NME family of proteins is composed of 10 isoforms, designated NME1-10, which are diverse in their enzymatic activities and patterns of subcellular localization. Each contains a conserved domain associated...
10.
Leonard M, Pamidimukkala N, Puts G, Snyder D, Slominski A, Kaetzel D
Int J Mol Sci
. 2017 Aug;
18(8).
PMID: 28788083
Cutaneous malignant melanoma is an aggressive and potentially lethal form of skin cancer, particularly in its advanced and therapy-resistant stages, and the need for novel therapeutics and prognostic tools is...